EMEA-000184-PIP03-16
Key facts
Invented name |
Tobi Podhaler
|
Active substance |
Tobramycin
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0114/2017
|
PIP number |
EMEA-000184-PIP03-16
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of Pseudomonas aeruginosa pulmonary colonisation in patients with bronchiectasis
|
Route(s) of administration |
Inhalation use
|
Contact for public enquiries |
Mylan IRE Healthcare Limited
E-mail: info.uk@viatris.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|